[
  {
    "ts": "2025-10-10T18:27:00+00:00",
    "headline": "Global Protein Drugs Market to Reach $655.7 Billion by 2029",
    "summary": "“BCC Research analyzes how innovation in biomanufacturing, ESG trends, and strategic investments are shaping the next frontier of protein-based therapeutics.”Boston, Oct. 10, 2025 (GLOBE NEWSWIRE) -- As demand for targeted, biologic-based treatments continues to grow, protein drugs are transforming how pharmaceutical companies address chronic, genetic, and life-threatening diseases. From monoclonal antibodies (mAbs) to peptide hormones and vaccines, global leaders such as AbbVie, Novo Nordisk an",
    "url": "https://finance.yahoo.com/news/global-protein-drugs-market-reach-182700529.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "aab318d5-ec43-3ed4-8018-371baae078f3",
      "content": {
        "id": "aab318d5-ec43-3ed4-8018-371baae078f3",
        "contentType": "STORY",
        "title": "Global Protein Drugs Market to Reach $655.7 Billion by 2029",
        "description": "",
        "summary": "“BCC Research analyzes how innovation in biomanufacturing, ESG trends, and strategic investments are shaping the next frontier of protein-based therapeutics.”Boston, Oct. 10, 2025 (GLOBE NEWSWIRE) -- As demand for targeted, biologic-based treatments continues to grow, protein drugs are transforming how pharmaceutical companies address chronic, genetic, and life-threatening diseases. From monoclonal antibodies (mAbs) to peptide hormones and vaccines, global leaders such as AbbVie, Novo Nordisk an",
        "pubDate": "2025-10-10T18:27:00Z",
        "displayTime": "2025-10-10T18:27:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/fbaf319e7ebfea18660b7dcdca522294",
          "originalWidth": 1200,
          "originalHeight": 300,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Jo_ouASZ7cr0j0c20jbPPQ--~B/aD0zMDA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/fbaf319e7ebfea18660b7dcdca522294.cf.webp",
              "width": 1200,
              "height": 300,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vg9HrNFHjZhOkNKsKIjHUw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/fbaf319e7ebfea18660b7dcdca522294.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/global-protein-drugs-market-reach-182700529.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/global-protein-drugs-market-reach-182700529.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "SAN.PA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T13:00:05+00:00",
    "headline": "Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?",
    "summary": "Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finance.yahoo.com/news/trending-stock-abbvie-inc-abbv-130005686.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "ba8da64e-9a48-37c1-a629-af3d59ccc11b",
      "content": {
        "id": "ba8da64e-9a48-37c1-a629-af3d59ccc11b",
        "contentType": "STORY",
        "title": "Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?",
        "description": "",
        "summary": "Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
        "pubDate": "2025-10-10T13:00:05Z",
        "displayTime": "2025-10-10T13:00:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba",
          "originalWidth": 900,
          "originalHeight": 745,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J2T_cDhaoaaQj0soPS_nNw--~B/aD03NDU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba.cf.webp",
              "width": 900,
              "height": 745,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sWMlcbg78JI.iCrZWAER9Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/trending-stock-abbvie-inc-abbv-130005686.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/trending-stock-abbvie-inc-abbv-130005686.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T06:59:03+00:00",
    "headline": "What to Expect From AbbVie's Q3 2025 Earnings Report",
    "summary": "Pharma giant AbbVie is gearing up to announce its third-quarter results by the end of October, and analysts expect a high single-digit growth in earnings.",
    "url": "https://www.barchart.com/story/news/35357421/what-to-expect-from-abbvie-s-q3-2025-earnings-report",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "0216b293-f16a-39fd-8de9-c6abba5f4ea0",
      "content": {
        "id": "0216b293-f16a-39fd-8de9-c6abba5f4ea0",
        "contentType": "STORY",
        "title": "What to Expect From AbbVie's Q3 2025 Earnings Report",
        "description": "",
        "summary": "Pharma giant AbbVie is gearing up to announce its third-quarter results by the end of October, and analysts expect a high single-digit growth in earnings.",
        "pubDate": "2025-10-10T06:59:03Z",
        "displayTime": "2025-10-10T06:59:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/64238080bff59af4053b9b813d879577",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Abbvie Inc logo and meds- by Ascannio via Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sV5dyhX8uDCJGzeCE4rkkw--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/barchart_com_477/64238080bff59af4053b9b813d879577.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6yl69TRTYNaI9jQOQ7CDCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/64238080bff59af4053b9b813d879577.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/35357421/what-to-expect-from-abbvie-s-q3-2025-earnings-report",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/expect-abbvies-q3-2025-earnings-065903215.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T15:47:25+00:00",
    "headline": "Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly",
    "summary": "By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with",
    "url": "https://finance.yahoo.com/news/next-medicine-deal-pfizer-analysts-154725765.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "e5bf718e-6bac-3c86-b376-03e4a0af73e4",
      "content": {
        "id": "e5bf718e-6bac-3c86-b376-03e4a0af73e4",
        "contentType": "STORY",
        "title": "Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly",
        "description": "",
        "summary": "By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with",
        "pubDate": "2025-10-10T15:47:25Z",
        "displayTime": "2025-10-10T15:47:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/21736555fa2542a359a019bfde739fbb",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "FILE PHOTO: The Pfizer logo is pictured on their headquarters building in the Manhattan borough of New York City, New York, U.S., November 9, 2020. REUTERS/Carlo Allegri/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZC_4u8KKl6ge5b9LszTFog--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/21736555fa2542a359a019bfde739fbb.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.cqdgPcBT28.iZJmhZaOKg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/21736555fa2542a359a019bfde739fbb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/next-medicine-deal-pfizer-analysts-154725765.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/next-medicine-deal-pfizer-analysts-154725765.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]